These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12965950)

  • 41. Vasospasm and stroke attributable to ephedra-free xenadrine: case report.
    Holmes RO; Tavee J
    Mil Med; 2008 Jul; 173(7):708-10. PubMed ID: 18700609
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hidden amphetamines: from smoking cessation to diabetes.
    Prescrire Int; 2004 Feb; 13(69):18-20. PubMed ID: 15055218
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ephedra-containing dietary supplements in the US versus ephedra as a Chinese medicine.
    Mehendale SR; Bauer BA; Yuan CS
    Am J Chin Med; 2004; 32(1):1-10. PubMed ID: 15154280
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nonpigmenting solitary fixed drug eruption caused by a Chinese traditional herbal medicine, ma huang (Ephedra Hebra), mainly containing pseudoephedrine and ephedrine.
    Matsumoto K; Mikoshiba H; Saida T
    J Am Acad Dermatol; 2003 Apr; 48(4):628-30. PubMed ID: 12664035
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of the stimulant content of dietary supplements marketed as "ephedra-free".
    Gregory PJ
    J Herb Pharmacother; 2007; 7(1):65-72. PubMed ID: 17594988
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ephedra in perspective--a current review.
    Abourashed EA; El-Alfy AT; Khan IA; Walker L
    Phytother Res; 2003 Aug; 17(7):703-12. PubMed ID: 12916063
    [TBL] [Abstract][Full Text] [Related]  

  • 47. FDA issues alert on ephedra supplements in the USA.
    Nelson R
    Lancet; 2004 Jan; 363(9403):135. PubMed ID: 14733193
    [No Abstract]   [Full Text] [Related]  

  • 48. Toxicity and drug interactions associated with herbal products: ephedra and St. John's Wort.
    Holstege CP; Mitchell K; Barlotta K; Furbee RB
    Med Clin North Am; 2005 Nov; 89(6):1225-57. PubMed ID: 16227061
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Ephedra products from the Internet: dangerous herb].
    Kaulen H
    Dtsch Med Wochenschr; 2004 Feb; 129(9):420. PubMed ID: 15017985
    [No Abstract]   [Full Text] [Related]  

  • 50. Psychiatric effects of ephedra use: an analysis of Food and Drug Administration reports of adverse events.
    Maglione M; Miotto K; Iguchi M; Jungvig L; Morton SC; Shekelle PG
    Am J Psychiatry; 2005 Jan; 162(1):189-91. PubMed ID: 15625222
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Time to ban ephedra--now.
    Guharoy R; Noviasky JA
    Am J Health Syst Pharm; 2003 Aug; 60(15):1580-2. PubMed ID: 12951759
    [No Abstract]   [Full Text] [Related]  

  • 52. [Perioperative management of chronic treatment and medical devices. Phytotherapy].
    Baillard C;
    Ann Fr Anesth Reanim; 2011 Feb; 30(2):200. PubMed ID: 21316907
    [No Abstract]   [Full Text] [Related]  

  • 53. Electrocardiographic and hemodynamic effects of a multicomponent dietary supplement containing ephedra and caffeine: a randomized controlled trial.
    McBride BF; Karapanos AK; Krudysz A; Kluger J; Coleman CI; White CM
    JAMA; 2004 Jan; 291(2):216-21. PubMed ID: 14722148
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Herbal safety.
    Stapleton H
    RCM Midwives J; 2002 Mar; 5(3):104. PubMed ID: 11917412
    [No Abstract]   [Full Text] [Related]  

  • 55. Working to get ephedra banned.
    Consum Rep; 2003 Feb; 68(2):6. PubMed ID: 12516584
    [No Abstract]   [Full Text] [Related]  

  • 56. An acute clinical trial evaluating the cardiovascular effects of an herbal ephedra-caffeine weight loss product in healthy overweight adults.
    Kalman D; Incledon T; Gaunaurd I; Schwartz H; Krieger D
    Int J Obes Relat Metab Disord; 2002 Oct; 26(10):1363-6. PubMed ID: 12355332
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analysis of ephedra-free labeled dietary supplements sold in the San Francisco Bay area in 2003.
    Tam JW; Dennehy CE; Ko R; Tsourounis C
    J Herb Pharmacother; 2006; 6(2):1-19. PubMed ID: 17182481
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Coronary thrombosis related to use of Xenadrine RFA.
    Sachdeva R; Sivasankaran S; Fishman RF; Zarich SW; McPherson CA
    Tex Heart Inst J; 2005; 32(1):74-7. PubMed ID: 15902827
    [TBL] [Abstract][Full Text] [Related]  

  • 59. "Ephedra-free" diet pill-induced psychosis.
    Retamero C; Rivera T; Murphy K
    Psychosomatics; 2011; 52(6):579-82. PubMed ID: 22054631
    [No Abstract]   [Full Text] [Related]  

  • 60. Short-term and long-term in vivo exposure to an ephedra- and caffeine-containing metabolic nutrition system does not induce cardiotoxicity in B6C3F1 mice.
    Ray S; Phadke S; Patel C; Hackman RM; Stohs S
    Arch Toxicol; 2005 Jun; 79(6):330-40. PubMed ID: 15895207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.